Dr. Vinnedge tests novel breast cancer therapeutics and works to identify biomarkers of disease and disease progression from patient samples.

Allie Greene graduated from Virginia Tech with BS degrees in Biological Sciences and Psychology. She is currently a PhD student in the Neuroscience program at UC. Allie joined the Privette Vinnedge lab in February of 2019 and is co-mentored by behavioral neuroscientist Matia Solomon, PhD. She uses cell culture and murine models to study the role of the DEK protein and cooperating environmental and biological factors, such as stress or sex hormones, in the development and progression of dementia.

Megan Johnstone completed her PhD in Cellular and Molecular Nutrition at the University of Tennessee at Knoxville in 2016. While there she studied the effect of inflammation on colorectal cancer cell metabolism. In 2017 she joined the Privette-Vinnedge lab to explore the oncogenic role of DEK in cell culture and murine models.

Lois Parks has a BS in Molecular and Cellular Biology from Cedarville University. In 2019, she joined the Privette Vinnedge lab as a research assistant. She uses 3D cell culture and murine models to explore the functional significance of Wnt expression for DEK-induced oncogenic phenotypes.

Miranda Shephard has a BS in biological sciences from Northern Kentucky University and joined the lab in 2016 as a research assistant. She uses cell culture and mouse models to study the oncogenic roles of DEK and how DEK expression creates downstream paracrine signals to create a pro-tumorigenic micro environment.

Katherine is an undergraduate biology student at Xavier University graduating in May 2019. She joined the Privette Vinnedge laboratory in January 2018 as a laboratory aide. Katherine assists with projects looking at the impact of elevated DEK expression in animal models of mammary gland development and tumorigenesis.